Eco R1 Capital, LLC Tango Therapeutics, Inc. Transaction History
Eco R1 Capital, LLC
- $3.51 Billion
- Q1 2024
A detailed history of Eco R1 Capital, LLC transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Eco R1 Capital, LLC holds 13,330,736 shares of TNGX stock, worth $114 Million. This represents 3.02% of its overall portfolio holdings.
Number of Shares
13,330,736
Previous 13,330,736
-0.0%
Holding current value
$114 Million
Previous $132 Million
19.8%
% of portfolio
3.02%
Previous 3.8%
Shares
7 transactions
Others Institutions Holding TNGX
# of Institutions
127Shares Held
88.8MCall Options Held
2KPut Options Held
1.6K-
Trv Gp Iv, LLC Boston, MA19.2MShares$165 Million73.88% of portfolio
-
Boxer Capital, LLC San Diego, CA8.2MShares$70.3 Million3.39% of portfolio
-
Nextech Invest Ag5.53MShares$47.5 Million8.22% of portfolio
-
Southpoint Capital Advisors LP New York, NY5.28MShares$45.3 Million0.95% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.32MShares$37.1 Million0.02% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $756M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...